PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland.\', \'Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland. Electronic address: hubert.mado@med.sum.edu.pl.\', \'Department of Infectious Diseases and Hepatology, Medical University of Silesia, Katowice, Poland.\', \'Department of Otorhinolaryngology and Oncological Laryngology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0303-8467(20)30794-010.1016/j.clineuro.2020.106451
?:doi
?:hasPublicationType
?:journal
  • Clinical neurology and neurosurgery
is ?:pmid of
?:pmid
?:pmid
  • 33388661
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.719
?:rankingScore_hIndex
  • 61
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2/COVID-19 in multiple sclerosis patients receiving disease-modifying therapy.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all